xIPOmeter
Alzheon
Alzheon develops drugs against Alzheimer's disease and other disorders. Its ALZ-801 medication is going through the third phase of clinical trials. The company is headquartered in Framingham, Massachusetts.
NewsHeat chart
- Week
- Month
- Year
- Media news
- Corp news
The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice
Company Valuation
- Valuation
- Share Price
- Cumulative Funding
The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.
News related to Alzheon54
AlzheonAlzheon Announces Appointment of Renowned Investor and ...
FRAMINGHAM, Mass., January 07, 2025--Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates and ...
https://finance.yahoo.com/news/alzheon-announces-appointment-renowned-investor-110000750.htmlAlzheonAlzheon Announces Appointment of Renowned Investor and ...
Alzheon, Inc. is a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates and diagnostic assays for patients suffering from ...
https://www.morningstar.com/news/business-wire/20250107118892/alzheon-announces-appointment-of-renowned-investor-and-financial-executive-muneer-a-satter-to-board-of-directorsAlzheonNew Alzheon Peer-Reviewed Scientific Publication Describes Study ...
Alzheon, Inc. is a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates and diagnostic assays for patients suffering from ...
https://www.morningstar.com/news/business-wire/20240918661823/new-alzheon-peer-reviewed-scientific-publication-describes-study-design-and-baseline-characteristics-from-apolloe4-phase-3-trial-of-oral-alz-801valiltramiprosate-in-apoe44-homozygous-individuals-with-early-alzheimers-diseaseAlzheonNew Alzheon Peer-Reviewed Scientific Publication Describes Study ...
FRAMINGHAM, Mass., September 18, 2024--Alzheon, Inc., a clinical-stage biopharmaceutical company developing a portfolio of product candidates and diagnostic ...
https://finance.yahoo.com/news/alzheon-peer-reviewed-scientific-publication-100000222.htmlAlzheonAlzheon to Present Phase 2 Biomarker Trial Results and Baseline ...
Alzheon, Inc. is a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates and diagnostic assays for patients suffering from ...
https://www.morningstar.com/news/business-wire/20240723403529/alzheon-to-present-phase-2-biomarker-trial-results-and-baseline-characteristics-from-apolloe4-phase-3-trial-of-oral-alz-801valiltramiprosate-in-patients-with-early-alzheimers-disease-at-alzheimers-association-international-conference
Show more (49)